kabutan

Fuso Pharmaceutical Industries,Ltd.(4538) Summary

4538
TSE Prime
Fuso Pharmaceutical Industries,Ltd.
2,223
JPY
0
(0.00%)
Apr 28, 3:30 pm JST
13.96
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
8.2
PBR
0.55
Yield
4.05%
Margin Trading Ratio
22.59
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
2,232 JPY 14.00 USD
Previous Close Apr 27
2,223 JPY 13.94 USD
High Apr 28, 9:00 am
2,232 JPY 14.00 USD
Low Apr 28, 1:23 pm
2,208 JPY 13.86 USD
Volume
20,800
Trading Value
0.05B JPY 0.29M USD
VWAP
2217.9 JPY 13.93 USD
Minimum Trading Value
222,300 JPY 1,396 USD
Market Cap
0.02T JPY 0.13B USD
Number of Trades
90
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
Mid
1-Year Average
93
1-Year High Sep 19, 2025
545
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 6,400 55,500 8.67
Apr 17, 2026 4,900 47,400 9.67
Apr 10, 2026 5,100 42,600 8.35
Apr 3, 2026 7,700 45,200 5.87
Mar 27, 2026 405,300 46,000 0.11
Company Profile
Fuso Pharmaceutical Industries, Ltd. is a leading manufacturer of artificial kidney dialysis solutions and holds a high market share in blood-related pharmaceuticals. The company also produces medical devices and generic drugs.
Sector
Pharmaceuticals
Fuso Pharmaceutical Industries, Ltd. primarily engages in the manufacture and sale of medical pharmaceuticals and medical equipment. In the field of medical pharmaceuticals, the company focuses on the production and distribution of injectable solutions, particularly infusion fluids, and artificial kidney dialysis agents. Additionally, the company undertakes contract manufacturing of pharmaceuticals and develops generic drugs. Beyond its pharmaceutical operations, Fuso has established a presence in the real estate sector through property leasing. By encompassing a wide range of activities from manufacturing to sales, primarily in the medical field, Fuso has built a diversified revenue structure.